Ashwagandha 120 mg by Thorne

If your days feel wired and your nights feel restless, ashwagandha for stress is a practical first step. It fits adults with high job load, new parents running on light sleep, and athletes during heavy training blocks. If your Cortisol, AM runs high or your sleep tracker shows poor sleep efficiency, this low-dose, high-potency extract is a match. It is also reasonable if your hs-CRP (an inflammation marker) is mildly elevated and you want a non-sedating calming agent before looking at prescriptions.

This formula uses Shoden ashwagandha, standardized to 35% withanolide glycosides, the compounds that drive most effects. These signal the HPA axis (the stress-control loop between brain and adrenals) to temper cortisol output, which is why many users feel calmer within 2 to 4 weeks. Ashwagandha also nudges GABA signaling (the brain’s main calming pathway) and, in some trials, improved sleep latency and efficiency. Small studies show modest drops in hs-CRP in responders. A minority see higher thyroid output, so monitor TSH and Free T4 if you have thyroid disease.

One capsule daily is the manufacturer’s guidance. Take with food if you have a sensitive stomach; take in the evening if your main goal is sleep. Shoden is concentrated, so 120 mg here is not a “micro” dose; it approximates typical effects seen with 300–600 mg of conventional root extracts. Expect stress and mood changes within 2 to 4 weeks and sleep gains by 4 to 8 weeks. Reassess at 8 to 12 weeks with your Cortisol, AM or a simple sleep log.

Skip ashwagandha if you are pregnant or breastfeeding. Use caution with thyroid medication, since ashwagandha can slightly raise thyroid hormone in some people; check TSH and Free T4 within 6 to 8 weeks. Sedatives and alcohol can have additive calming effects. Rare liver irritation has been reported; if you have liver disease or elevated ALT, discuss with your clinician and monitor. Autoimmune conditions or use of immunosuppressants warrant a case-by-case call rather than self-directed use.